Treating neural conditions resulting from spinal cord contusions and other causes
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Nov 14, 2006
Grant Date -
N/A
app pub date -
Jul 7, 2000
filing date -
Jul 7, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
.beta..sub.2-agonists, such as clenbuterol and salbutamol can enhance the recovery of locomotive function and/or neuromuscular strength following spinal cord injuries or as a result of degenerative neural conditions such as Mnd. Pharmacological compositions for treating spinal cord injuries and degenerative neural conditions are also provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully